I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Fruchart, Jean-Charles
362
results:
Search for persons
X
Format
Online (362)
Mediatypes
Articles (Online) (285)
Bookchapter (Online) (1)
OpenAccess-fulltext (75)
Thesis (Online) (1)
Languages
english (342)
more...
french (5)
spanish (1)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Lessons from PROMINENT and prospects for pemafibrate:
Fruchart, Jean-Charles
;
Fruchart-Najib, Jamila
;
Yamashita, Shizuya
...
Cardiovascular Diabetology. 23 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1186/..
?
2
Selective PPARα Modulator Pemafibrate and Sodium-Glucose Co..:
Murakami, Kentaro
;
Sasaki, Yusuke
;
Asahiyama, Masato
...
Cells. 11 (2022) 4 - p. 720 , 2022
Link:
https://doi.org/10.3390/..
?
3
Selective Peroxisome Proliferator-Activated Receptor Alpha ..:
Fruchart, Jean-Charles
;
Hermans, Michel P.
;
Fruchart-Najib, Jamila
.
Current Atherosclerosis Reports. 23 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1007/..
?
4
Selective Peroxisome Proliferator–Activated Receptor Alpha ..:
Fruchart, Jean-Charles
;
Hermans, Michel P.
;
Fruchart-Najib, Jamila
Current Atherosclerosis Reports. 22 (2020) 8 - p. , 2020
Link:
https://doi.org/10.1007/..
?
5
Pemafibrate, a selective PPARα modulator, prevents non-alco..:
Sasaki, Yusuke
;
Asahiyama, Masato
;
Tanaka, Toshiya
...
Scientific Reports. 10 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1038/..
?
6
Waist circumference as a vital sign in clinical practice: a..:
Ross, Robert
;
Neeland, Ian J.
;
Yamashita, Shizuya
...
Nature Reviews Endocrinology. 16 (2020) 3 - p. 177-189 , 2020
Link:
https://doi.org/10.1038/..
?
7
Residual vascular risk in diabetes – Will the SPPARM alpha ..:
Fruchart, Jean-Charles
;
Santos, Raul D.
;
Yamashita, Shizuya
...
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 13 (2019) 4 - p. 2723-2725 , 2019
Link:
https://doi.org/10.1016/..
?
8
Visceral and ectopic fat, atherosclerosis, and cardiometabo..:
Neeland, Ian J
;
Ross, Robert
;
Després, Jean-Pierre
...
The Lancet Diabetes & Endocrinology. 7 (2019) 9 - p. 715-725 , 2019
Link:
https://doi.org/10.1016/..
?
9
The selective peroxisome proliferator-activated receptor al..:
Fruchart, Jean-Charles
;
Santos, Raul D.
;
Aguilar-Salinas, Carlos
...
Cardiovascular Diabetology. 18 (2019) 1 - p. , 2019
Link:
https://doi.org/10.1186/..
?
10
Rationale and design of the Pemafibrate to Reduce Cardiovas..:
Pradhan, Aruna D.
;
Paynter, Nina P.
;
Everett, Brendan M.
...
American Heart Journal. 206 (2018) - p. 80-93 , 2018
Link:
https://doi.org/10.1016/..
?
11
Pemafibrate (K-877), a novel selective peroxisome prolifera..:
Fruchart, Jean-Charles
Cardiovascular Diabetology. 16 (2017) 1 - p. , 2017
Link:
https://doi.org/10.1186/..
?
12
Effects of K-877, a novel selective PPARα modulator (SPPARM..:
Ishibashi, Shun
;
Yamashita, Shizuya
;
Arai, Hidenori
...
Atherosclerosis. 249 (2016) - p. 36-43 , 2016
Link:
https://doi.org/10.1016/..
?
13
PCSK9: The functional relevance of fenofibrate–statin combi..:
Fruchart, Jean-Charles
International Journal of Diabetes Mellitus. 3 (2015) 1 - p. 4-10 , 2015
Link:
https://doi.org/10.1016/..
?
14
Residual macrovascular risk in 2013: what have we learned?:
for the Residual Risk Reduction Initiative (R3i)
;
Fruchart, Jean-Charles
;
Davignon, Jean
...
Cardiovascular Diabetology. 13 (2014) 1 - p. , 2014
Link:
https://doi.org/10.1186/..
?
15
Selective peroxisome proliferator-activated receptorα modul..:
Fruchart, Jean-Charles
Cardiovascular Diabetology. 12 (2013) 1 - p. 82 , 2013
Link:
https://doi.org/10.1186/..
1-15